Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05865405 · ClinicalTrials.gov registry record · NA
A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis
A NA study of Depression and Multiple Sclerosis, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05865405: Active NA study of Depression and Multiple Sclerosis, sponsored by University of California, San Francisco.
NCT05865405 is a NA study of Depression and Multiple Sclerosis that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05865405, a NA study of Depression and Multiple Sclerosis, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers want to find out if an electronic application called MS CATCH can enhance patients' and doctors' experiences during and in between clinical visits. MS CATCH is a smartphone-based tool which allows patients to enter their mood related symptoms at regular intervals, which is then available to their Neurologist in their electronic medical record. The neurologist is also able to view additional information from their medical record, and receives alerts for changes reported by the patient that raise concern for the patient's mental health.
Primary Outcome
Clinician screening of depression as documented in the electronic health record (EHR)
Conditions Studied
Interventions
- BEHAVIORAL MS CATCH
Study Locations (1)
California
- Weill Institute for Neurosciences, University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2026-08-15 |
| Phase | NA |
What the registry record for NCT05865405 still lists
NCT05865405 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which MS CATCH is the first listed.
NCT05865405 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05865405 about?
NCT05865405 is a clinical study titled "A Closed Loop, Doctor to Patient, Mobile Application for Depression in People With Multiple Sclerosis". The researchers want to find out if an electronic application called MS CATCH can enhance patients' and doctors' experiences during and in between clinical visits. MS CATCH is a smartphone-based tool which allows patients to enter their mood related symptoms at regular intervals, which is then avail...
What is the current status of trial NCT05865405?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-08-01. Estimated completion is 2026-08-15.
What conditions does trial NCT05865405 study?
This clinical trial studies the following conditions: Depression, Multiple Sclerosis, MS.
What interventions are being tested in trial NCT05865405?
The interventions under investigation include: MS CATCH (BEHAVIORAL).
Who is sponsoring clinical trial NCT05865405?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05865405 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05865405's enrollment target sits among peer trials
100 326th of 679 higher than 331 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy